Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking naproxen with Mounjaro is not formally contraindicated, but there are genuine reasons to think carefully before combining them. Naproxen is an NSAID; Mounjaro (tirzepatide) slows gastric emptying, which can alter how oral medicines are absorbed and may compound the stomach irritation NSAIDs already carry. Your prescriber needs to know about every medicine you take before starting tirzepatide. Mounjaro is a prescription-only medicine available only following a clinical assessment, and a prescriber decides whether it is suitable for your circumstances.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide activates GIP and GLP-1 receptors, two gut-hormone pathways that together slow how quickly food) and anything else in your stomach, moves through to the small intestine. That slowing is partly why people feel full sooner. It also means oral medicines sit in the stomach longer than they otherwise would before absorption begins.
For most drugs this effect is modest. For naproxen specifically, delayed gastric emptying could extend the time before pain relief kicks in, and it means the drug spends longer in contact with gastric tissue. That is relevant because naproxen already inhibits the prostaglandins that protect the stomach lining. The NHS medicines guidance on tirzepatide flags that it may affect how other oral medicines are absorbed, and advises patients to tell their prescriber and pharmacist about every medicine they take before starting treatment.
This is not a theoretical concern buried in a footnote. Our prescribers hear this question regularly from people who take NSAIDs for chronic joint pain or back pain. The answer is never simply yes or no, it depends on why you take naproxen, how often, and at what dose, alongside the full picture of your health.
You can read more about Mounjaro's mechanism and its broader interaction profile on our tirzepatide overview page.
Naproxen's most common side effects are gastrointestinal: nausea, stomach pain, heartburn, and in some cases ulceration or bleeding with prolonged use. Mounjaro's most common side effects are also gastrointestinal: nausea, vomiting, diarrhoea, constipation, and reflux. Prescribers look at what happens when both are present at once.
There are two compounding risks worth naming clearly. First, the combined GI burden. Someone just starting Mounjaro (or moving up to a new dose) is often managing nausea that can last days to weeks. Adding naproxen during that window raises the chance of significant stomach discomfort. Second, kidney strain. NSAIDs reduce renal perfusion. Severe vomiting or diarrhoea from tirzepatide causes fluid loss that the kidneys have to compensate for. The NHS highlights dehydration and kidney problems as one of the signs to take seriously on GLP-1 treatment, and regular NSAID use tightens that margin further.
That said, occasional, short-course naproxen for a headache or a pulled muscle is a very different picture from daily high-dose use for osteoarthritis. The detailed guide to naproxen and Mounjaro interactions covers these distinctions in more depth.
The MHRA's Yellow Card scheme lets patients report any unexpected reactions, including suspected interactions, at yellowcard.mhra.gov.uk.
If you already take naproxen regularly and are considering Mounjaro, bring both medicines into the consultation. A prescriber can look at your reason for taking naproxen, how frequently, whether an alternative analgesic (paracetamol, for instance, does not carry the same gastric or renal risk profile) might work for you, and whether any monitoring is appropriate. Starting tirzepatide without mentioning a regular NSAID is the kind of gap that matters.
If you are already on Mounjaro and reaching for naproxen occasionally, the practical guidance is: take it with food or milk if you normally do so, stay well hydrated, keep the course short, and let your prescriber know if you are using it regularly. If you experience severe or persistent stomach pain (especially pain that travels through to your back) that is a symptom requiring urgent medical attention regardless of which medicine caused it. The NHS tirzepatide guidance on the NHS medicines pages sets out the full list of side effects to watch for.
Other medicines that interact with tirzepatide's gastric-emptying effect are worth understanding too. The question of combining other GLP-1 medicines with Mounjaro is a separate but related topic our prescribers are often asked about. For those managing symptoms alongside HRT, the HRT and Mounjaro guide covers what NHS England specifically advises on that combination. If you follow a plant-based diet and want to know whether Mounjaro is suitable for vegans, we cover the ingredients and excipients in detail on a dedicated page. And if you are curious about less-discussed supplements on treatment, the NAD and Mounjaro page addresses a question that comes up more often than you might expect.
If you have a question about your current medicines and whether Mounjaro is right for you, our prescribers are the right people to ask. Speak to our prescribers through a free consultation, your answers are read the same day by a GPhC-registered Independent Prescriber, not processed by software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.